Hims & Hers Q2 rev $545M (+73%), net income $42.5M, reaffirms FY25

Hims & Hers Health, Inc.

2025-Q2 EPS reported $0.37 vs consensus $0.15 ▲ beat (+140.1%)

Revenue $544.8M (+73% YoY); net income $42.5M (vs $13.3M); Adj EBITDA $82.2M (vs $39.3M).
Subscribers 2.44M (+31% YoY); monthly online revenue per subscriber $74 (+30% YoY).
Gross margin 76% (down ~500 bps YoY); free cash flow -$69.4M (vs +$47.6M prior year).
FY25 guidance reaffirmed: revenue $2.3-2.4B and Adj EBITDA $295-335M.
Acquired ZAVA Global (European digital health); expects $50M+ revenue from ZAVA in H2 at positive EBITDA.

item 2.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.